Brinker Capital Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$771K Sell
3,193
-217
-6% -$52.4K 0.01% 1329
2025
Q1
$831K Buy
3,410
+146
+4% +$35.6K 0.01% 1178
2024
Q4
$1.07M Sell
3,264
-219
-6% -$71.9K 0.01% 1013
2024
Q3
$1.17M Sell
3,483
-201
-5% -$67.3K 0.01% 964
2024
Q2
$1.01M Sell
3,684
-367
-9% -$100K 0.01% 988
2024
Q1
$1.4M Sell
4,051
-2,048
-34% -$708K 0.02% 833
2023
Q4
$1.96M Sell
6,099
-2,012
-25% -$648K 0.02% 642
2023
Q3
$2.91M Sell
8,111
-340
-4% -$122K 0.04% 457
2023
Q2
$3.2M Buy
8,451
+604
+8% +$229K 0.03% 457
2023
Q1
$3.76M Sell
7,847
-206
-3% -$98.7K 0.05% 341
2022
Q4
$3.39M Buy
8,053
+1,387
+21% +$583K 0.07% 290
2022
Q3
$2.78M Buy
6,666
+681
+11% +$284K 0.06% 332
2022
Q2
$2.96M Sell
5,985
-184
-3% -$91.1K 0.06% 324
2022
Q1
$3.48M Sell
6,169
-2,835
-31% -$1.6M 0.05% 340
2021
Q4
$6.8M Sell
9,004
-2,148
-19% -$1.62M 0.1% 200
2021
Q3
$7.23M Buy
11,152
+3
+0% +$1.95K 0.11% 183
2021
Q2
$7.18M Buy
11,149
+5,168
+86% +$3.33M 0.1% 225
2021
Q1
$3.42M Sell
5,981
-12,266
-67% -$7.01M 0.05% 345
2020
Q4
$10.6M Buy
18,247
+10,280
+129% +$5.99M 0.16% 137
2020
Q3
$4.11M Buy
7,967
+7,518
+1,674% +$3.88M 0.07% 282
2020
Q2
$203K Buy
+449
New +$203K 0.01% 305
2020
Q1
Sell
-448
Closed -$166K 349
2019
Q4
$166K Hold
448
0.01% 334
2019
Q3
$149K Hold
448
0.01% 345
2019
Q2
$140K Hold
448
﹤0.01% 434
2019
Q1
$137K Sell
448
-52
-10% -$15.9K ﹤0.01% 370
2018
Q4
$116K Hold
500
﹤0.01% 341
2018
Q3
$156K Hold
500
﹤0.01% 305
2018
Q2
$144K Hold
500
﹤0.01% 316
2018
Q1
$125K Buy
+500
New +$125K ﹤0.01% 305